Flow Traders U.S.’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Flow Traders U.S.’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,894	Closed	-$268K	–	1087
2022 Q3	$268K	Sell	8,894 -3,868	-30%	-$122K	0.01%	660
2022 Q2	$353K	Sell	12,762 -2,832	-18%	-$80.8K	0.02%	576
2022 Q1	$525K	Buy	15,594 +6,390	+69%	+$221K	0.02%	544
2021 Q4	$389K	Sell	9,204 -2,151	-19%	-$95.9K	0.02%	550
2021 Q3	$517K	Sell	11,355 -825	-7%	-$37.9K	0.02%	692
2021 Q2	$596K	Buy	+12,180	New	+$583K	0.03%	545

Other funds holding SBIO

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Flow Traders U.S.'s SBIO Position: Q4 2022 in Review

Flow Traders U.S. sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2022, closing a stake of 8,894 shares — an estimated $268K sold.

Flow Traders U.S. first reported a position in SBIO in Q2 2021 and held it in 6 quarters. The position peaked at $596K in Q2 2021. 48 funds tracked by Wall St. Rank hold SBIO as of Q4 2022.

Flow Traders U.S. reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2022 after selling out during the quarter.
Flow Traders U.S. sold 8,894 ALPS Medical Breakthroughs ETF shares in Q4 2022, an estimated $268K.
Flow Traders U.S. first reported a position in ALPS Medical Breakthroughs ETF in Q2 2021 and held it in 6 quarters.
Flow Traders U.S.'s ALPS Medical Breakthroughs ETF position peaked at $596K in Q2 2021.
48 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2022.

Based on Flow Traders U.S.'s 13F filing for Q4 2022, filed 14 Feb 2023.